ARB2A (ARB2 cotranscriptional regulator A) is a nuclear protein that regulates alternative splicing through interactions with AGO2 and CHD7 at the chr5-spliceosome interface 1. The gene contains an Arb2 domain associated with histone H3 lysine 9 methylation and exhibits alternative splicing with multiple transcript variants 2. ARB2A functions as a direct binding partner of AGO2, facilitating AGO2 nuclear import via a classical bipartite nuclear localization signal and the canonical importin-α/β pathway, a process enhanced by CK2-induced phosphorylation 1. The protein plays roles in neural crest cell development and regulatory ncRNA-mediated heterochromatin formation. Clinically, ARB2A dysregulation is implicated in cancer progression. In pancreatic cancer, ARB2A suppresses epithelial-to-mesenchymal transition via ERK-MAPK signaling inhibition 3, and its downregulation is associated with therapeutic resistance to hydroxychloroquine 4. In follicular thyroid carcinoma, ARB2A is aberrantly upregulated and promotes tumorigenesis through Erk1/2 and JNK pathways, with potential diagnostic utility 5. In colon cancer, ARB2A inhibits proliferation and promotes apoptosis through STAT1-mediated transcriptional regulation 6, representing a tumor suppressor function. CHARGE syndrome-associated mutations in related proteins affecting this pathway underscore its clinical relevance 1.